Schizoaffective Disorders Completed Phase 4 Trials for Ramelteon (DB00980)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00595504Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With SchizophreniaTreatment